z-logo
open-access-imgOpen Access
Unlocking the potential with the use of check-point inhibitor immunotherapies in metastatic prostate cancer
Author(s) -
Swaroop Revannasiddaiah,
Ishu Gupta,
Santhosh Kumar Devadas
Publication year - 2019
Publication title -
chinese clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.733
H-Index - 22
eISSN - 2304-3873
pISSN - 2304-3865
DOI - 10.21037/cco.2019.01.07
Subject(s) - medicine , prostate cancer , immunotherapy , cancer , radiation therapy , oncology , prostate , hormonal therapy , modalities , chemotherapy , social science , sociology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom